HeartSciences Inc.
No SEC Form 4 filings for $HSCS in the last 30 days.
See all $HSCS insider activity →Eloxx Pharmaceuticals (ELOX) rose 20% after FDA cleared its Phase 2b trial for exaluren. Vogenx (VOGX) gained 14% post-IPO. Arcturus (ARCT) advanced 21% on pipeline updates. Zhengye (ZYBT) +7% after Nasdaq compliance. Greenwich (GLSI) +10% on extended lock-up. HeartSciences (HSCS) +8% after $1M investment. AC Immune (ACIU) +8% on Phase 1 data.
HeartSciences Inc. (HSCS) received a $1 million investment from Fortitude Mining Holdings at a 22% premium, buying 411,522 shares at $2.43 each. Fortitude now owns 9.4% of HSCS stock. The deal strengthens HSCS's balance sheet ahead of a planned merger in late 2026. HSCS stock is up 10.33% to $2.35.
HeartSciences Inc. (HSCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ea030250401ex10-1.htm SUBSCRIPTION AGREEMENT, DATED AS OF AUGUST 12, 2026, BETWEEN HEARTSCIENCES AND FORTITUDE MINING HOLDINGS, INC Exhibit 10.1 Execution version SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “ Subscription Agreement ”) is entered into on Aug
Over the past 7 days, alphai's AI scored 3 news stories mentioning HSCS (HeartSciences Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent HSCS coverage spans corporate actions, earnings and mergers & acquisitions.
Capital infusion strengthens balance sheet ahead of a merger.
The infusion improves balance sheet and may boost short-term price momentum.
The filing discloses a near-term equity issuance tied to the company’s pending merger transaction, which can affect dilution expectations and financing certainty.
The 8-K discloses a key M&A process milestone (preliminary proxy) and reiterates FDA review and product commercialization progress, which can re-rate deal odds and near-term financing needs.
The amendment is a material deal-structure update that can affect voting process, timing, and deal execution risk.
alphai scores every news story that mentions HSCS with an AI model for sentiment and relevance, and aggregates insider trades from HeartSciences Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Eloxx Pharmaceuticals (ELOX) rose 20% after FDA cleared its Phase 2b trial for exaluren. Vogenx (VOGX) gained 14% post-IPO. Arcturus (ARCT) advanced 21% on pipeline updates. Zhengye (ZYBT) +7% after Nasdaq compliance. Greenwich (GLSI) +10% on extended lock-up. HeartSciences (HSCS) +8% after $1M investment. AC Immune (ACIU) +8% on Phase 1 data.
3 min readHeartSciences Inc. (HSCS) received a $1 million investment from Fortitude Mining Holdings at a 22% premium, buying 411,522 shares at $2.43 each. Fortitude now owns 9.4% of HSCS stock. The deal strengthens HSCS's balance sheet ahead of a planned merger in late 2026. HSCS stock is up 10.33% to $2.35.
2 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ea030250401ex10-1.htm SUBSCRIPTION AGREEMENT, DATED AS OF AUGUST 12, 2026, BETWEEN HEARTSCIENCES AND FORTITUDE MINING HOLDINGS, INC Exhibit 10.1 Execution version SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “ Subscription Agreement ”) is entered into on Aug
4 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029962701ex99-1.htm PRESS RELEASE, DATED JULY 29, 2026 Exhibit 99.1 HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results ● Company believes proposed
6 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001468492 0001468492 2026-07-27 2026-07-27 0001468492 us-gaap:CommonStockMember 2026-07-27 2026-07-27 0001468492 HSCS:WarrantsMember 2026-07-27 2026-07-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20
6 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.2 3 ea029748101ex10-2.htm RESTRICTED STOCK UNITS NOTICE OF GRANT AND RESTRICTED STOCK UNITS AGREEMENT, DATED AS OF JULY 7, 2026, BETWEEN HEARTSCIENCES AND DANIELLE WATSON Exhibit 10.2 HEARTSCIENCES INC. 2023 Equity Incentive Plan RESTRICTED STOCK UNITS GRANT NOTICE HeartSci
2 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.2 3 ea029612701ex10-2.htm NOTICE OF GRANT AND RESTRICTED STOCK AWARD AGREEMENT, DATED AS OF JUNE 22, 2026, BETWEEN HEARTSCIENCES AND ANDREW SIMPSON Exhibit 10.2 HEARTSCIENCES INC. NOTICE OF GRANT AND RESTRICTED STOCK AGREEMENT Subject to the terms and conditions of this Not
3 min readFortitude Mining Holdings, a Zcash miner, agreed to merge with HeartSciences Inc. (Nasdaq: HSCS) in an all-stock deal to take the combined company public. The firm is expected to trade on Nasdaq as “TUDE” under the Fortitude brand, with closing expected in 2H 2026. Fortitude reported ~$90M fiscal 2025 gross revenue and ~$20M adjusted EBITDA, and said 48 MW owned power could rise to ~80 MW by end-2026.
3 min readFortitude Mining Holdings and HeartSciences agreed to merge in an all-stock deal to create a public Zcash mining platform. The combined company is expected to trade under ticker TUDE pending approval, with a target close in H2 2026. Fortitude CEO Andrea Childs will lead the combined team; HeartSciences CEO Andrew Simpson will run the healthcare unit. Fortitude reported annualized 157,000 ZEC production as of May 31, 2026.
4 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 ea029545301ex2-1.htm MERGER AGREEMENT, DATED AS OF JUNE 23, 2026, AMONG HEARTSCIENCES, FORTITUDE MINING HOLDINGS, INC., FORTITUDE MINING HOLDCO, LLC AND CORDIS ACQUISITION, LLC Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among HeartSciences Inc., Co
4 min read
